Learn / TBPH
NASDAQ: TBPH
Theravance Biopharma (TBPH) stock, explained like you're 5
Theravance Biopharma trades on the Nasdaq under the ticker TBPH. It is a small cap company in the biotechnology industry, part of the healthcare sector, with a market value of about 883 million dollars.
- Ticker
- TBPH
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biotechnology
- Size
- Small cap, about 883 million dollars
Is Theravance Biopharma a small, medium or large cap company?
No. Theravance Biopharma is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 883 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Theravance Biopharma makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves TBPH stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- TBPH: Theravance Biopharma Inc Latest Stock Price, Analysis, News and Trading Ideas (Stocktwits)
- $17 a share in cash, plus rights to possible payments: a Theravance Biopharma (TBPH) director's shares convert. (Stock Titan)
- THERAVANCE BIOPHARMA ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY ZYMEWORKS FOR $17.00 PER SHARE IN CASH PLUS A CONTINGENT VALUE RIGHT (PR Newswire)
- Theravance Stock Down 3% After Zymeworks Announces Buyout (Yahoo Finance)
- Theravance Biopharma Inc (NASDAQ: TBPH) Share Price, TBPH Stock News, TBPH Share Price & Updates (Kalkine)
Follow TBPH in your daily brief
Each trading day at 5 PM ET we post what happened to Theravance Biopharma and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow TBPH
Questions about Theravance Biopharma stock
What does Theravance Biopharma do?
Theravance Biopharma trades on the Nasdaq under the ticker TBPH. It is a small cap company in the biotechnology industry, part of the healthcare sector, with a market value of about 883 million dollars.
What is the ticker symbol for Theravance Biopharma?
Theravance Biopharma trades under the ticker TBPH on the Nasdaq.
What is Theravance Biopharma's market cap?
Theravance Biopharma is a small cap stock with a market cap of about 883 million dollars.
How does Theravance Biopharma make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves TBPH stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow TBPH stock every day?
Add TBPH to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.